JPY7,858.00
0.44% today
Tokyo, Aug 27, 07:15 am CET
ISIN
JP3188220002
Symbol
4578
Index

Otsuka Holdings Stock price

JPY7,893.00
+883.00 12.60% 1M
+515.00 6.98% 6M
-707.00 8.22% YTD
-543.00 6.44% 1Y
+3,292.00 71.55% 3Y
+3,233.00 69.38% 5Y
+3,978.50 101.63% 10Y
+5,753.00 268.83% 20Y
Tokyo, Closing price Tue, Aug 26 2025
-127.00 1.58%
ISIN
JP3188220002
Symbol
4578
Index
Industry

Key metrics

Basic
Market capitalization
JPY4.2t
Enterprise Value
JPY4.0t
Net debt
positive
Cash
JPY436.6b
Shares outstanding
528.1m
Valuation (TTM | estimate)
P/E
10.2 | 13.6
P/S
1.8 | 1.7
EV/Sales
1.7 | 1.6
EV/FCF
12.7
P/B
1.6
Dividends
DPS
JPY130.00
Yield 1Y | 5Y
1.7% | 2.0%
Growth 1Y | 5Y
8.3% | 5.4%
Payout 1Y | 3Y
18.9% | 29.0%
Increased
2 Years
Financials (TTM | estimate)
Revenue
JPY2.4t | JPY2.4t
EBITDA
JPY537.8b | JPY518.6b
EBIT
JPY428.1b | JPY0.0
Net Income
JPY408.9b | JPY307.2b
Free Cash Flow
JPY315.3b
Growth (TTM | estimate)
Revenue
10.2% | 4.8%
EBITDA
17.3% | -1.2%
EBIT
21.1% | -100.0%
Net Income
222.4% | -10.5%
Free Cash Flow
89.3%
Margin (TTM | estimate)
Gross
72.1%
EBITDA
22.4% | 21.3%
EBIT
17.8%
Net
17.0% | 12.6%
Free Cash Flow
13.1%
Financial Health
Equity Ratio
73.1%
Return on Equity
12.6%
ROCE
13.8%
ROIC
15.4%
Debt/Equity
0.1
More
EPS
JPY774.1
FCF per Share
JPY597.0
Short interest
-
Employees
35k
Rev per Employee
JPY65.9m
Show more

Is Otsuka Holdings a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Otsuka Holdings Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Otsuka Holdings forecast:

10x Buy
63%
6x Hold
38%

Analyst Opinions

16 Analysts have issued a Otsuka Holdings forecast:

Buy
63%
Hold
38%

Financial data from Otsuka Holdings

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,401,697 2,401,697
10% 10%
100%
- Direct Costs 669,646 669,646
5% 5%
28%
1,732,051 1,732,051
12% 12%
72%
- Selling and Administrative Expenses 976,599 976,599
10% 10%
41%
- Research and Development Expense 333,187 333,187
8% 8%
14%
537,834 537,834
17% 17%
22%
- Depreciation and Amortization 109,735 109,735
4% 4%
5%
EBIT (Operating Income) EBIT 428,099 428,099
21% 21%
18%
Net Profit 408,854 408,854
222% 222%
17%

In millions JPY.

Don't miss a Thing! We will send you all news about Otsuka Holdings directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following business segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. Its products include Bon Curry, Mannan Hikari, and ReSOLA. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded in1950 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Makoto Inoue
Employees 35,338
Founded 1921
Website www.otsuka.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today